CZ20011764A3 - Agent interacting with potassium channel and use thereof - Google Patents
Agent interacting with potassium channel and use thereofInfo
- Publication number
- CZ20011764A3 CZ20011764A3 CZ20011764A CZ20011764A CZ20011764A3 CZ 20011764 A3 CZ20011764 A3 CZ 20011764A3 CZ 20011764 A CZ20011764 A CZ 20011764A CZ 20011764 A CZ20011764 A CZ 20011764A CZ 20011764 A3 CZ20011764 A3 CZ 20011764A3
- Authority
- CZ
- Czechia
- Prior art keywords
- potassium channel
- agent interacting
- interacting
- agent
- potassium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10933398P | 1998-11-20 | 1998-11-20 | |
US11003398P | 1998-11-25 | 1998-11-25 | |
US11027798P | 1998-11-30 | 1998-11-30 | |
US09/298,731 US6369197B1 (en) | 1998-11-20 | 1999-04-23 | Potassium channel interactors and uses therefor |
US09/350,874 US20020019020A1 (en) | 1998-11-20 | 1999-07-09 | Methods for treating cardiovascular disorders |
US09/350,614 US6689581B1 (en) | 1998-11-20 | 1999-07-09 | Potassium channel interactors and uses therefor |
US09/400,492 US7115381B1 (en) | 1998-11-20 | 1999-09-21 | Methods for treating cardiovascular disorders |
US09/399,913 US6361971B1 (en) | 1998-11-20 | 1999-09-21 | Nucleic acid molecules encoding potassium channel interactors and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ20011764A3 true CZ20011764A3 (en) | 2002-01-16 |
Family
ID=27574798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ20011764A CZ20011764A3 (en) | 1998-11-20 | 1999-11-19 | Agent interacting with potassium channel and use thereof |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1131349A2 (en) |
JP (1) | JP2002530104A (en) |
CN (1) | CN1346368A (en) |
AU (1) | AU775713B2 (en) |
BR (1) | BR9915513A (en) |
CA (1) | CA2351365A1 (en) |
CZ (1) | CZ20011764A3 (en) |
IL (1) | IL143148A0 (en) |
MX (1) | MXPA01004903A (en) |
NO (1) | NO20012471L (en) |
NZ (1) | NZ512332A (en) |
WO (1) | WO2000031133A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6369197B1 (en) | 1998-11-20 | 2002-04-09 | Millennium Pharmaceuticals, Inc. | Potassium channel interactors and uses therefor |
US7078481B1 (en) | 1998-11-20 | 2006-07-18 | Wyeth | Potassium channel interactors and uses therefor |
EA200300420A1 (en) * | 2000-09-27 | 2004-04-29 | Милленниум Фамэсьютикэлс, Инк. | Isolated nucleic acid molecules, isolated polypeptides AND METHOD FOR PRODUCTION THEREOF, METHOD FOR DETECTING THEM present in the sample (VARIANTS) host cell (VARIANTS) antibody kit (OPTIONS), a method of modulating activity of a polypeptide, IDENTIFICATION METHOD (VARIANTS) AND APPLICATION OF COMPOUNDS METHOD OF IDENTIFICATION OF THE SUBJECT (OPTIONS) AND METHOD OF TREATING THE SUBJECT WITH DAMAGE ASSOCIATED WITH POTASSIUM CHANNELS (OPTIONS) |
AU2009312751B8 (en) * | 2008-11-06 | 2015-04-09 | Basf Se | A screening assay for insecticides |
GB201906482D0 (en) * | 2019-05-08 | 2019-06-19 | Evox Therapeutics Ltd | Exosome comprising stabilized RNA therapeutics |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998016185A2 (en) * | 1996-10-17 | 1998-04-23 | Nps Pharmaceuticals, Inc. | Potassium channel blocking compounds and their use |
US6117989A (en) * | 1998-03-26 | 2000-09-12 | Incyte Pharmaceuticals, Inc. | Human calcium-binding proteins |
-
1999
- 1999-11-19 NZ NZ512332A patent/NZ512332A/en unknown
- 1999-11-19 IL IL14314899A patent/IL143148A0/en unknown
- 1999-11-19 MX MXPA01004903A patent/MXPA01004903A/en unknown
- 1999-11-19 JP JP2000583959A patent/JP2002530104A/en not_active Withdrawn
- 1999-11-19 WO PCT/US1999/027428 patent/WO2000031133A2/en not_active Application Discontinuation
- 1999-11-19 CZ CZ20011764A patent/CZ20011764A3/en unknown
- 1999-11-19 AU AU14797/00A patent/AU775713B2/en not_active Ceased
- 1999-11-19 CA CA002351365A patent/CA2351365A1/en not_active Abandoned
- 1999-11-19 BR BR9915513-3A patent/BR9915513A/en not_active IP Right Cessation
- 1999-11-19 CN CN99815642A patent/CN1346368A/en active Pending
- 1999-11-19 EP EP99972644A patent/EP1131349A2/en not_active Withdrawn
-
2001
- 2001-05-18 NO NO20012471A patent/NO20012471L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000031133A2 (en) | 2000-06-02 |
NO20012471D0 (en) | 2001-05-18 |
JP2002530104A (en) | 2002-09-17 |
IL143148A0 (en) | 2002-04-21 |
NZ512332A (en) | 2004-02-27 |
NO20012471L (en) | 2001-07-18 |
MXPA01004903A (en) | 2003-03-10 |
WO2000031133A3 (en) | 2000-10-05 |
CA2351365A1 (en) | 2000-06-02 |
EP1131349A2 (en) | 2001-09-12 |
CN1346368A (en) | 2002-04-24 |
BR9915513A (en) | 2002-02-05 |
AU1479700A (en) | 2000-06-13 |
AU775713B2 (en) | 2004-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9812413D0 (en) | Compound and its use | |
IL183948A (en) | Peg-urate oxidase conjugates and use thereof | |
HUP0104270A3 (en) | Herbicidal composition and use thereof | |
HU9903361D0 (en) | Filter-device with collecting-vessel and with heating-device | |
IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
GB9813271D0 (en) | Composition and use | |
ZA200101933B (en) | Novel composition and use | |
GB9817235D0 (en) | Compound,composition and use | |
HUP0103636A3 (en) | 2-methyl-thieno-benzodiazepine formulation and its use | |
EP1056455A4 (en) | Epimorphian compound and its use | |
HUP0103473A3 (en) | Phosphoglycolipid and methods for its use | |
PL332616A1 (en) | Hydoxymethylhexanones as odorising and savourising agents | |
GB9817236D0 (en) | Compound,composition and use | |
GB9803232D0 (en) | Compound composition and use | |
CZ20011764A3 (en) | Agent interacting with potassium channel and use thereof | |
HUP0104723A3 (en) | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use | |
GB0100361D0 (en) | Compound, composition and use | |
SG80037A1 (en) | Potassium channel drugs and their uses | |
GB9805172D0 (en) | Composition and use | |
GB9826830D0 (en) | Potassium channel activators and their use | |
GB9911606D0 (en) | Composition and use | |
EP1077705A4 (en) | Potassium channel agonists | |
EP1066051A4 (en) | Sciellin and uses thereof | |
PL324932A1 (en) | Mould-killing agent | |
HK1046914A1 (en) | Potassium channel interactors and uses therefor |